Journal Article DKFZ-2026-01687

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Chemically synthesized, non-capped and non-polyadenylated peptide-coding RNA efficiently induces antigen-specific CD8+ T cells.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Nature Research Tokyo

Nature biomedical engineering nn, nn () [10.1038/s41551-026-01738-z]
 GO

Abstract: Recombinant in vitro-transcribed mRNA is broadly used for vaccination and is evaluated in numerous clinical studies for multiple indications. Typical features of mRNA are the 5' cap, 5' untranslated region, start and stop codons, 3' untranslated region and 3' poly(A) tail. Here, contrary to current dogma, we show that short, chemically synthesized RNA oligonucleotides lacking some or all of these features are efficiently translated when they encode epitopes recognized by CD8+ T cells. In particular, one design that we termed ChemRNA with the structure 5'-OH-AUG-coding sequence-3'-OH strongly stimulates antigen-specific CD8+ T cells both in vitro and in vivo. Our results challenge the current understanding of canonical mRNA structure and introduce the possibility that defective or supposedly non-coding RNA may encode human and murine major histocompatibility complex class I-associated peptides. Moreover, ChemRNA could help overcome challenges associated with the design and purification of individualized anti-cancer vaccines.

Classification:

Note: #DKTKZFB26# / epub

Contributing Institute(s):
  1. DKTK Koordinierungsstelle Tübingen (TU01)
Research Program(s):
  1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2026
Database coverage:
Medline ; Clarivate Analytics Master Journal List ; DEAL Nature ; Essential Science Indicators ; IF >= 25 ; JCR ; National-Konsortium ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-07-08, last modified 2026-07-09



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)